Original Research
Published on 12 Nov 2024
Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1480676
- 138 views
Type at least 3 characters
1,291 articles
Articles
Original Research
Accepted on 08 Nov 2024
In-depth analysis of serum antibodies against Epstein-Barr virus (EBV) lifecycle proteins and EBNA1, ANO2, GlialCAM and CRYAB peptides in patients with multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1487523
Case Report
Published on 07 Nov 2024
Case report: The case report of ofatumumab, a fully human anti-CD20 monoclonal antibody, in the treatment of KLHL11 encephalitis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1456840
- 125 views
Case Report
Published on 06 Nov 2024
Case report: Infectious mononucleosis with bilateral retinal haemorrhages under myelin oligodendrocyte glycoprotein antibody-associated disease
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1480134
- 165 views
Review
Accepted on 05 Nov 2024
Peripheral immune reactions following human traumatic spinal cord injury: the interplay of immune activation and suppression
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1495801
Case Report
Accepted on 05 Nov 2024
Thymic hyperplasia after autologous hematopoietic stem cell transplantation in multiple sclerosis: a case series
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1478777
Editorial
Published on 01 Nov 2024
Editorial: Community series in reassessing the immune system contribution in multiple sclerosis: therapeutic target, biomarkers of disease and immune pathogenesis, volume II
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1505829
- 188 views
Original Research
Published on 01 Nov 2024
Effects of early intervention in neuromyelitis optica spectrum disorder patients with seropositive AQP4 antibodies
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1458556
- 173 views
Case Report
Accepted on 31 Oct 2024
Telitacicept in combination with B-cell depletion therapy in MuSK antibody-positive myasthenia gravis: A case report and literature review
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1456822
Original Research
Accepted on 30 Oct 2024
The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1443940
Original Research
Accepted on 29 Oct 2024
Global Perspectives on the Contribution of B Cells to Multiple Sclerosis: An In-depth Examination and Evaluation
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1442694
Original Research
Accepted on 28 Oct 2024
Stimulation of microneedles alleviates pathology of Parkinson's disease in mice by regulating the CD4+/CD8+ cells from the periphery to the brain
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1454102
General Commentary
Published on 23 Oct 2024
Commentary: Evaluation of the causal effects of immune cells on ischemic stroke: a Mendelian randomization study
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1450086
- 358 views
Review
Accepted on 22 Oct 2024
A review focuses on a neglected and controversial component of SCI: myelin debris
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1436031
Case Report
Published on 22 Oct 2024
Elevation of serum neurofilament light-chain levels disclose possible occult progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient receiving ozanimod: a case report
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1465678
- 392 views
Perspective
Published on 22 Oct 2024
The arisal of data spaces: why I am excited and worried
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2024.1461361
- 241 views